Home » XECHEM SELLS OWNERSHIP INTEREST IN CEPTOR
XECHEM SELLS OWNERSHIP INTEREST IN CEPTOR
Xechem International has completed the sale of the majority of its interest in CepTor Corporation in a transaction with CepTor that resulted in cash proceeds to Xechem of $2.3 million. CepTor is a former Xechem corporate spin-off that has been operating as an independent entity since February of this year following the successful completion of its $12 million private equity offering. Upon the closing of the sale, Xechem was left with 500,000 shares of CepTor's common stock, or 15% of its original investment.
KEYWORDS Daily International Pharma Alert
Upcoming Events
-
07May
-
14May
-
30May